190 related articles for article (PubMed ID: 18979397)
1. [Testicular cancer - explanatory models for high cisplatin chemosensibility and new therapeutic options].
Ebbing J; Christoph F; Kempkensteffen C; Weikert S; Schostak M; Hinz S; Lein M; Miller K; Schrader M
Aktuelle Urol; 2008 Nov; 39(6):429-35. PubMed ID: 18979397
[TBL] [Abstract][Full Text] [Related]
2. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
de Haas EC; Zwart N; Meijer C; Nuver J; Boezen HM; Suurmeijer AJ; Hoekstra HJ; van der Steege G; Sleijfer DT; Gietema JA
J Clin Oncol; 2008 Apr; 26(11):1817-23. PubMed ID: 18398146
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of gene expression of human tumor cells in testicular tumor].
Niclas C; Sparwasser C
Urologe A; 2007 Sep; 46(9):1185. PubMed ID: 17690861
[No Abstract] [Full Text] [Related]
4. [The role of chemotherapy in the treatment of testicular cancer with the exception of seminomas].
Kenis Y; Piccart M; Beer M
Rev Med Brux; 1983 Apr; 4(4):219-23. PubMed ID: 6192477
[No Abstract] [Full Text] [Related]
5. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
[TBL] [Abstract][Full Text] [Related]
6. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours?
Pizzocaro G; Guarneri A
Eur Urol; 2009 Jul; 56(1):46-7. PubMed ID: 19303203
[No Abstract] [Full Text] [Related]
7. Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.
Mendoza J; Martínez J; Hernández C; Pérez-Montiel D; Castro C; Fabián-Morales E; Santibáñez M; González-Barrios R; Díaz-Chávez J; Andonegui MA; Reynoso N; Oñate LF; Jiménez MA; Núñez M; Dyer R; Herrera LA
Br J Cancer; 2013 Jul; 109(1):68-75. PubMed ID: 23807173
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
Bokemeyer C
J Clin Oncol; 2008 Apr; 26(11):1783-5. PubMed ID: 18398143
[No Abstract] [Full Text] [Related]
9. [Therapy of germ cell tumors. Model for interdisciplinary treatment approach].
Schmoll HJ
Med Klin (Munich); 1996 Apr; 91 Suppl 3():80-4. PubMed ID: 8692125
[No Abstract] [Full Text] [Related]
10. Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.
Korkola JE; Houldsworth J; Bosl GJ; Chaganti RS
BJU Int; 2009 Nov; 104(9 Pt B):1334-8. PubMed ID: 19840009
[TBL] [Abstract][Full Text] [Related]
11. Poor-prognosis germ cell tumors: we have not yet crossed the finish line.
Vaughn DJ; Stadtmauer EA
J Clin Oncol; 2007 Jan; 25(3):239-40. PubMed ID: 17235039
[No Abstract] [Full Text] [Related]
12. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.
Cavallo F; Feldman DR; Barchi M
Int J Dev Biol; 2013; 57(2-4):273-80. PubMed ID: 23784838
[TBL] [Abstract][Full Text] [Related]
13. Stage I testicular cancer management and necessity for surgical expertise.
Sheinfeld J; Motzer RJ
J Clin Oncol; 2008 Jun; 26(18):2934-6. PubMed ID: 18458042
[No Abstract] [Full Text] [Related]
14. Disseminated testicular cancer: current chemotherapy strategies.
Williams SD; Loehrer PJ; Nichols CR; Roth BJ; Einhorn LH
Semin Oncol; 1989 Aug; 16(4 Suppl 6):105-9. PubMed ID: 2548281
[TBL] [Abstract][Full Text] [Related]
15. [A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
Yanada S; Ito H; Tomita M; Wada T; Hatano T; Kishimoto K; Egawa S
Hinyokika Kiyo; 2008 Jan; 54(1):43-6. PubMed ID: 18260360
[TBL] [Abstract][Full Text] [Related]
16. Third-line chemotherapy and novel agents for metastatic germ cell tumors.
Veenstra CM; Vaughn DJ
Hematol Oncol Clin North Am; 2011 Jun; 25(3):577-91, ix. PubMed ID: 21570610
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
Vaughn DJ
Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
[TBL] [Abstract][Full Text] [Related]
18. Survival from testicular cancer in England and Wales up to 2001.
Huddart RA
Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S83-5. PubMed ID: 18813271
[No Abstract] [Full Text] [Related]
19. [The role of cytostatic polychemotherapy in the treatment of germinal testicular tumors].
Hegenscheid M; Möhner M; Schulze H
Z Urol Nephrol; 1990 Jun; 83(6):297-302. PubMed ID: 2171247
[No Abstract] [Full Text] [Related]
20. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]